Boston Scientific Corp at Leerink Partners Global Healthcare Conference Transcript
Okay. Let's get started. Good morning, everyone. My name's Danielle Antalffy. I am one of the medtech analysts here at SVB Leerink. And we are very lucky to have with us from Boston Scientific, Joe Fitzgerald. He is EVP and President of Rhythm Management; as well as Susie Lisa, Head of Investor Relations. And this is going to be fireside chat format, should we just launch right into Q&A? And if anyone has a question, feel free to raise your hand. And if you're lucky, maybe I'll call on you. No, I'm kidding.
Questions & Answers
Okay. So Joe, at your Analyst Day, you talked about Rhythm Management being a $14 billion market, growing at about 3%. Can you talk about any possible market adjacencies that could potentially grow this addressable market? And given your category leadership strategy, what's the right way to think
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |